Litcius/Paper detail

Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis

Garima Kaushik, Parthasarathy Seshacharyulu, Sanchita Rauth, Palanisamy Nallasamy, Satyanarayana Rachagani, Rama Krishna Nimmakayala, Raghupathy Vengoji, Kavita Mallya, Ramakanth Chirravuri‐Venkata, Amar B. Singh, Jason M. Foster, Quan P. Ly, Lynette M. Smith, Subodh M. Lele, Mokenge P. Malafa, Maneesh Jain, Moorthy P. Ponnusamy, Surinder K. Batra

2020Oncogene57 citationsDOIOpen Access PDF

Topics & Concepts

GemcitabineAfatinibMetastasisCancer researchCancer stem cellPancreatic cancerCancerBiologyEpithelial–mesenchymal transitionInternal medicineOncologyMedicineEpidermal growth factor receptorErlotinibCancer Cells and MetastasisPancreatic and Hepatic Oncology ResearchFOXO transcription factor regulation
Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis | Litcius